文献速递脑血管病外科

栓塞后放射外科治疗脑动静脉畸形

Embolization Followed by Radiosurgery for the Treatment of Brain Arteriovenous Malformations (AVMs).
PubMed 文献 · World Neurosurg · 2016-12-23

回顾性分析1995至2009年91例脑动静脉畸形患者,先栓塞后放射外科治疗。栓塞后畸形团中位体积从18.8 mL降至9.9 mL(P<0.00003),改良RBAS评分从2.6降至1.8(P<0.00003)。栓塞后2例(2.2%)出现新固定神经功能缺损,无新发致残性缺损(mRS>2)。71例随访超过3年,40例(56%)完全闭塞,38例(53%)获优良结局。

要点

  • 栓塞后放射外科治疗脑动静脉畸形,栓塞后畸形团中位体积从18.8 mL降至9.9 mL,P<0.00003。
  • 栓塞后2.2%(2/91)出现新固定神经功能缺损,无新发致残性缺损(mRS>2)。
  • 随访超过3年的71例中,56%(40/71)完全闭塞,53%(38/71)获优良结局。

核心结论

  • 这些数据提示,脑动静脉畸形栓塞能安全有效地在放射外科治疗前缩小治疗体积。
  • 栓塞联合放射外科治疗似乎不 adverse 影响优良结局率。

研究设计与样本

  • 回顾性综述本院动静脉畸形数据库,纳入1995年至2009年接受栓塞后放射外科治疗的91例患者。
  • 栓塞前后用血管造影测量动静脉畸形体积,并计算改良放射外科动静脉畸形评分(RBAS)。
  • 将栓塞前体积得出的RBAS与放射外科治疗后闭塞进行相关性分析。

主要发现

  • 栓塞后中位动静脉畸形体积从18.8 mL(四分位距10.2-32.2 mL)降至9.9 mL(3.1-19.2 mL),P<0.00003。
  • 中位RBAS评分从2.6 mL(1.8-3.9 mL)降至1.8 mL(1.0-2.8 mL),P<0.00003。
  • 91例中2例(2.2%)栓塞后出现新固定神经功能缺损,无患者出现新发致残性缺损(改良Rankin量表评分>2)。
  • 91例中71例(79%)随访超过3年,其中40例(56%)完全闭塞,38例(53%)获优良结局(完全闭塞且无神经功能下降)。
  • 改良RBAS评分<1、1-1.5、1.5-2和>2的患者中,优良结局率分别为90%、66%、50%和43%。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Embolization has been proposed to reduce the size of the arteriovenous malformation (AVM) nidus in advance of radiosurgical treatment. Embolization followed by radiosurgery for brain AVMs, however, is controversial. OBJECTIVE: We assessed the impact of embolization on nidal size before radiosurgical treatment and evaluated cure rates and complications by using embolization followed by radiosurgery. METHODS: A retrospective review of our institutional AVM database identified 91 patients treated from 1995 to 2009 with embolization followed by radiosurgery. Pre- and postembolization AVM volumes were measured with angiography, and the modified radiation-based AVM scores (RBAS) also were calculated pre- and postembolization. RBAS determined from pre-embolization volumes were correlated with postradiosurgical obliteration. RESULTS: Median AVM volume declined from 18.8 mL (interquartile range, 10.2-32.2 mL) to 9.9 mL (3.1-19.2 mL) after embolization, P < 0.00003. Median RBAS scores decreased from 2.6 mL (1.8-3.9 mL) to 1.8 mL (1.0-2.8 mL), P < 0.00003. Two of 91 (2.2%) had new fixed deficits after embolization; however, no patient had new disabling deficits (modified Rankin Scale score >2). A total of 71 of 91 (79%) have had >3 years' follow-up, and 40 (56%) had complete obliteration, with 38 (53%) having excellent outcomes (complete obliteration without neurologic decline). Excellent outcome was seen in 90% of patients with modified RBAS score <1, 66% of patients with score 1-1.5, 50% patients with score 1.5-2, and 43% of patients with score >2. CONCLUSIONS: These data suggest that embolization of brain AVMs can safely and effectively reduce the treatment volume before radiosurgery. Combined therapy with embolization and radiosurgery does not appear to adversely affect rates of excellent outcome.

来源:World Neurosurg,查看原文。版权归原作者所有。

引用

  1. Marks MP, Marcellus ML, Santarelli J, et al. Embolization Followed by Radiosurgery for the Treatment of Brain Arteriovenous Malformations (AVMs). World Neurosurg. 2016. PMID: 28017742. doi:10.1016/j.wneu.2016.12.059

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。